Board of Scientific Counselors, Office of Infectious Diseases: Notice of Charter Renewal, 71804 [2015-29258]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
71804
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Influenza
Coordination Unit (CVA4).
Delete in its entirety the title and
function statements for the National
Center for Immunization and
Respiratory Diseases (CVG) and insert
the following:
National Center for Immunization
and Respiratory Diseases (CVG). The
National Center for Immunization and
Respiratory Diseases (NCIRD) prevents
disease, disability, and death through
immunization and by control of
respiratory and related diseases. In
carrying out its mission, NCIRD: (1)
Provides leadership, expertise, and
service in laboratory and
epidemiological sciences, and in
immunization program delivery; (2)
conducts applied research on disease
prevention and control; (3) translates
research findings into public health
policies and practices; (4) provides
diagnostic and reference laboratory
services to relevant partners; (5)
conducts surveillance and research to
determine disease distribution,
determinants, and burden nationally
and internationally; (6) responds to
disease outbreaks domestically and
abroad; (7) ensures that public health
decisions are made objectively and
based upon the highest quality of
scientific data; (8) provides technical
expertise, education, and training to
domestic and international partners; (9)
provides leadership to internal and
external partners for establishing and
maintaining immunization, and other
prevention and control programs; (10)
develops, implements, and evaluates
domestic and international public
health policies; (11) communicates
information to increase awareness,
knowledge, and understanding of public
health issues domestically and
internationally, and to promote effective
immunization programs; (12) aligns the
national center focus with the overall
strategic goals of CDC; (13) synchronizes
all aspects of CDC’s pandemic influenza
preparedness and response from
strategy through implementation and
evaluation; and (14) implements,
coordinates, and evaluates programs
across NCIRD, Office of Infectious
Diseases (OID), and CDC to optimize
public health impact.
After the Office of Science and
Integrated Programs (CVG17) insert the
following:
Influenza Coordination Unit (CVG18).
The mission of the Influenza
Coordination Unit (ICU) is to
synchronize all aspects of CDC’s
VerDate Sep<11>2014
18:14 Nov 16, 2015
Jkt 238001
pandemic influenza preparedness and
response from strategy through
implementation and evaluation. In
carrying out its mission, the ICU: (1)
Serves as the principal advisor to the
CDC Director on pandemic influenza
preparedness and response activities,
assisting the Director in formulating and
communicating strategic pandemic
initiatives and policies; (2) provides
strategic leadership for CDC in the areas
of pandemic preparedness and
response, including setting priorities
and promoting science, policies, and
programs related to pandemic influenza;
(3) strategically manages a budget and
allocates funds across the agency to
ensure appropriate resources for high
priority areas; and (4) conducts ongoing
evaluation and adjustment of pandemic
preparedness and response activities, in
coordination with the National
Response Framework and other
emergency preparedness guidance, to
ensure optimal public health
effectiveness and efficient use of human
and fiscal resources by developing and
leading an exercise program for the
Agency, in collaboration with HHS and
other partners.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–29276 Filed 11–16–15; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases: Notice of
Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, Office of
Infectious Diseases, Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS), has been renewed for a
2-year period through October 31, 2017.
For information, contact Robin
Moseley, M.A.T., Designated Federal
Officer, Board of Scientific Counselors,
Office of Infectious Diseases, CDC, HHS,
1600 Clifton Road NE., Mailstop D10,
Atlanta, Georgia 30329–4027, telephone
404/639–4461 or fax 404/235–3562.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29258 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0964]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Page 71804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29258]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases:
Notice of Charter Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Board of Scientific Counselors,
Office of Infectious Diseases, Centers for Disease Control and
Prevention (CDC), Department of Health and Human Services (HHS), has
been renewed for a 2-year period through October 31, 2017.
For information, contact Robin Moseley, M.A.T., Designated Federal
Officer, Board of Scientific Counselors, Office of Infectious Diseases,
CDC, HHS, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30329-
4027, telephone 404/639-4461 or fax 404/235-3562.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-29258 Filed 11-16-15; 8:45 am]
BILLING CODE 4163-18-P
